Growth hormone treatment and bone mineral density in pediatric patients with Prader-Willi syndrome

Clicks: 177
ID: 274659
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #12 of 13 articles by views in journal of pediatric endocrinology & metabolism : jpem

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The BMD-SDS of patients with PWS decreases gradually despite GH treatment. As there are no clear recommendations about monitoring of bone health in patients with PWS, further studies are needed to improve the guidelines for screening of BMD and treatment of patients with PWS.
Reference Key
y2021journalgrowth Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oto Y;Murakami N;Inoue T;Matsubara K;Saima S;Ogata H;Ihara H;Nagai T;Matsubara T;;
Journal journal of pediatric endocrinology & metabolism : jpem
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34162033
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34162033 doi:10.1515/jpem-2021-0061 yuji oto nobuyuki murakami tomoyo matsubara

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.